June 2026 Regulatory Update: Traceability Protocols for CJC-1295 and Ipamorelin Blends
A clinical review of June 2026 documentation updates for CJC-1295 and Ipamorelin peptide blends, focusing on in-vitro traceability and laboratory compliance. As of June 2026, the research peptide sector has observed a stringent shift in documentation requirements. Umbrella Lab recently announced com…